Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond T Chung

Showing results (81-90 of 616) with videos related to

Pageof 62
Sort By:
Journal of Hepatology|August 21, 2024
Reply to: "Changes of hepatic myeloid cells in chronic viral hepatitis and after cure and their clinical significance"Ang Cui, Raymond T Chung, Nadia Alatrakchi
Seminars in Liver Disease|December 23, 2011
The impact of human gene polymorphisms on HCV infection and disease outcomeEsperance A K Schaefer, Raymond T Chung
Cellular and Molecular Gastroenterology and Hepatology|January 27, 2022
A New Model to Assess Hepatitis B Virus Covalently Closed Circular DNA: A Window Into a Previously Hidden Space?Min Xu, Wenyu Lin, Raymond T Chung
Hepatology (Baltimore, Md.)|December 31, 2009
An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cellsHisashi Moriguchi, Raymond T Chung, Chifumi Sato
Oncotarget|September 8, 2016
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitroKaku Goto, Naoya Kato, Raymond T Chung
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
Porphyria cutanea tardaPatrick Yachimski, Nirali Shah, Raymond T Chung
Seminars in Liver Disease|November 14, 2013
HCV and host lipids: an intimate connectionEsperance A K Schaefer, Raymond T Chung
Gastroenterology|April 28, 2012
Anti-hepatitis C virus drugs in developmentEsperance A K Schaefer, Raymond T Chung
Hepatology (Baltimore, Md.)|December 4, 2009
An indicator for evaluating the risk of cancerous transformations of human induced pluripotent stem cellsHisashi Moriguchi, Raymond T Chung, Chifumi Sato
Hepatology (Baltimore, Md.)|December 4, 2009
New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cellsHisashi Moriguchi, Raymond T Chung, Chifumi Sato
Pageof 62

Showing results (81-90 of 616) with videos related to

Sort By:
Pageof 62
Journal of Hepatology|August 21, 2024
Reply to: "Changes of hepatic myeloid cells in chronic viral hepatitis and after cure and their clinical significance"Ang Cui, Raymond T Chung, Nadia Alatrakchi
Seminars in Liver Disease|December 23, 2011
The impact of human gene polymorphisms on HCV infection and disease outcomeEsperance A K Schaefer, Raymond T Chung
Cellular and Molecular Gastroenterology and Hepatology|January 27, 2022
A New Model to Assess Hepatitis B Virus Covalently Closed Circular DNA: A Window Into a Previously Hidden Space?Min Xu, Wenyu Lin, Raymond T Chung
Hepatology (Baltimore, Md.)|December 31, 2009
An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cellsHisashi Moriguchi, Raymond T Chung, Chifumi Sato
Oncotarget|September 8, 2016
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitroKaku Goto, Naoya Kato, Raymond T Chung
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
Porphyria cutanea tardaPatrick Yachimski, Nirali Shah, Raymond T Chung
Seminars in Liver Disease|November 14, 2013
HCV and host lipids: an intimate connectionEsperance A K Schaefer, Raymond T Chung
Gastroenterology|April 28, 2012
Anti-hepatitis C virus drugs in developmentEsperance A K Schaefer, Raymond T Chung
Hepatology (Baltimore, Md.)|December 4, 2009
An indicator for evaluating the risk of cancerous transformations of human induced pluripotent stem cellsHisashi Moriguchi, Raymond T Chung, Chifumi Sato
Hepatology (Baltimore, Md.)|December 4, 2009
New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cellsHisashi Moriguchi, Raymond T Chung, Chifumi Sato
Pageof 62